Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-23-035684)

Filing Details

Accession Number:: 0000950170-23-035684
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-07-31 07:59:27
Reporting Period:: 2023-07-27

Accepted Time:: 2023-07-31 07:59:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832415	Better Therapeutics Inc.	BTTX	Services-Health Services (8000)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1890348	A. Mark Berman	C/O Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco CA 94104	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-07-27	54,802	$0.73	388,191	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
As one of the PIPE Investors, the Reporting Person acquired 54,802 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.